-

BioTek reMEDys Celebrates National IV Nurse Day

Specialty Infusion Pharmacy Company Shines a Light on the Work of IV Nurses While Promoting the Importance of Continuation of Care and Safe Medication Use

NEW CASTLE, Del.--(BUSINESS WIRE)--In honor of today being National IV Nurse Day, BioTek reMEDys, one of the nation’s largest independent specialty infusion pharmacies focused on rare diseases, is calling for enhanced education and awareness of safe medication use for patients with rare diseases and conditions, while also celebrating and drawing attention to the tremendous contributions of IV Nurses nationwide.

Founded by the Infusion Nurse Society, an international nonprofit organization representing infusion nurses and other clinicians who are engaged in the specialty practice of infusion therapy, National IV Nurse Day is celebrated each year on January 25th to recognize the decades of continuing education, advocacy, and professional development that have driven the infusion specialty.

“As a specialty pharmacy company focused on the highly specific needs of patients living with rare conditions, we are very much aware of the integral role IV nurses play in the healthcare continuum,” said Chai Gadde, CEO and founder of BioTek reMEDys. “National IV Nurse Day is a time to recognize the vital contributions and powerful impact these professionals – who we proudly work alongside on a daily basis – have on the patient population, and on the healthcare system as a whole. We are passionate about shining a spotlight on these nurses’ efforts to ensure that IV medication use is safe and patients are achieving optimal outcomes.”

BioTek reMEDys provides therapy-specific patient education materials and its National Customer Support Center is available 24 hours a day, seven days a week to help patients and their loved ones manage critical aspects of care. By servicing very specific disease states, BioTek reMEDys’ expert team can maintain its focus on patient care – making sure that dosages and treatments are appropriate.

As an example of BioTek reMEDys’ dedication to advocacy and education surrounding rare conditions, the company will be exhibiting at the State of Texas Association of Rheumatologists (STAR) Annual Meeting in Houston, February 3-5; and Texas Neurological Society (TNS) Annual Winter Conference in Austin, February 3-5.

To learn more about National IV Nurse Day, visit ins1.org/about-us/iv-nurse-day.

Founded in 2011, BioTek reMEDys, based in New Castle, DE, has become one of the nation’s largest independent infusion pharmacies focused on home infusion. Chai Gadde opened the pharmacy to meet the specific needs of patients who require specialty medications. BioTek reMEDys and its affiliates are now licensed to operate in all 50 states. For information visit www.biotekrx.com.

Contacts

Paul Williams
paul@medialinecommunications.com
310/569-0023

BioTek reMEDys


Release Versions

Contacts

Paul Williams
paul@medialinecommunications.com
310/569-0023

Social Media Profiles
More News From BioTek reMEDys

BioTek reMEDys Encourages Education and Awareness for Autoinflammatory Conditions

NEW CASTLE, Del.--(BUSINESS WIRE)--BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for year-round enhanced education and awareness of these rare diseases and conditions. Autoinflammatory diseases refer to problems with the innate immune system’s reactions. Immune cells target the body’s own healthy tissues by mistake, signaling the body to attack them. This can cause intense episodes of inf...

BioTek reMEDys Celebrates the Work of Collaborating Healthcare Professionals During National Interprofessional Healthcare Month

NEW CASTLE, Del.--(BUSINESS WIRE)--In recognition of National Interprofessional Healthcare Month, BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, is publicly calling for awareness of safe medication use for patients with rare diseases and conditions, while celebrating the critical contributions and collaborative spirit of healthcare professionals nationwide, applauding the efforts of those who impact the patie...

BioTek reMEDys Names Neal Fitzpatrick Chief Strategy Officer

NEW CASTLE, Del.--(BUSINESS WIRE)--BioTek reMEDys, a multi-site national integrated infusion therapy provider focused on providing support to people with rare diseases, has named Neal C. Fitzpatrick as its Chief Strategy Officer. Fitzpatrick recently served as Chief Commercial Officer at a biotech company, charged with leading the organization through a period of high growth. Before this, he served as Vice-President of Sales at ADMA Biologics, where he repositioned an essential product from hos...
Back to Newsroom